Delivery Order SPE2DB20D3101-SPE2DB25FRTU7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count supply) with a ceiling value of $51,539.65. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a competitively awarded contract with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a $3,689.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Entresto 24 mg-26 mg tablets (60-count supply) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-competitive delivery order was placed against AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,962.22 on August 4, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count). This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $24,605.54 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) under a firm fixed price contract type. This delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive award with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at approximately $24,925 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) under a firm fixed-price contract. The award was made on August 15, 2025, with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical delivery order....
- The Defense Logistics Agency (DLA) awarded a $32,989.70 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This non-set-aside, firm fixed-price contract was awarded through open competition and reflects AmerisourceBergen's established role as a critical pharmaceutical distributor within the federal medical supply chain. The delivery order is being performed at...
- The Defense Logistics Agency awarded a $14,010.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count units). The contract, which is not set-aside and was competitively awarded, has an ultimate completion date of July 31, 2025. AmerisourceBergen Drug Corp will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor for...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $33,369.67 to supply Entresto 24 mg-26 mg tablets (180-count units). This non-competitive, firm fixed price delivery order was awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a standard pharmaceutical supply transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $8,325.99 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60 count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract is performed at the awardee's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $68,784.07 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 49 mg-51 mg tablets (180-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a direct fulfillment under the company's broader pharmaceutical supply arrangements. The place of performance is AmerisourceBergen's corporate office location...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRTU7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for supply of Entresto 24 mg-26 mg tablets (180-count package) with a ceiling value of $41,948.42. This competitively awarded, firm fixed-price delivery order was established on August 28, 2025, with an ultimate completion date of August 29, 2025, and represents a non-set-aside procurement. The order will be fulfilled at AmerisourceBergen's Conshohocken facility and supports federal medical procurement needs across the Department of Defense healthcare system. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The DLA Troop Support Medical supply chain encompasses critical medications across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard, demonstrating AmerisourceBergen's role as a critical vendor within the federal medical supply infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.9k | 8/28/25 |